Tazare, John

Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February

Grint, D. J., Wing, K., Williamson, E., McDonald, H. I., Bhaskaran, K., Evans, D., Evans, S. J., Walker, A. J., Hickman, G., Nightingale, E., et al. (2021) · Eurosurveillance

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 189

Safety of COVID-19 vaccination and acute neurological events: a self-controlled case series in England using the OpenSAFELY platform

Walker, J. L., Schultze, A., Tazare, J., Tamborska, A., Singh, B., Donegan, K., Stowe, J., Morton, C. E., Hulme, W. J., Curtis, H. J., et al. (2022) · Vaccine

SARS-CoV-2 and COVID-19 ResearchPharmacovigilance and Adverse Drug Reactions

Cited by 30